CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 13 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-13 | Shah Nikita SVP, Chief HR Officer | Returned to the company · Stock Option | −72,661 | 0 | ||
| 2019-11-13 | Shah Nikita SVP, Chief HR Officer | Grant or award · Stock Option | +72,661 | 72,661 | ||
| 2019-11-13 | Shah Nikita SVP, Chief HR Officer | Returned to the company · Stock Option | −95,525 | 0 | ||
| 2019-11-13 | Shah Nikita SVP, Chief HR Officer | Grant or award · Stock Option | +95,525 | 95,525 | ||
| 2019-11-13 | Bhadauria Pradeep SVP, Chief Scientific Officer | Returned to the company · Stock Option | −153,846 | 0 | ||
| 2019-11-13 | Bhadauria Pradeep SVP, Chief Scientific Officer | Grant or award · Stock Option | +153,846 | 153,846 | ||
| 2019-11-13 | BOYER ANDREW S Exec VP, Comm Optns | Returned to the company · Stock Option | −272,480 | 0 | ||
| 2019-11-13 | BOYER ANDREW S Exec VP, Comm Optns | Grant or award · Stock Option | +272,480 | 272,480 | ||
| 2019-11-13 | BOYER ANDREW S Exec VP, Comm Optns | Returned to the company · Stock Option | −100,553 | 0 | ||
| 2019-11-13 | BOYER ANDREW S Exec VP, Comm Optns | Grant or award · Stock Option | +100,553 | 100,553 | ||
| 2019-11-13 | Branning Todd P. SVP, Chief Financial Officer | Returned to the company · Stock Option | −163,666 | 0 | ||
| 2019-11-13 | Branning Todd P. SVP, Chief Financial Officer | Grant or award · Stock Option | +163,666 | 163,666 | ||
| 2019-11-11 | Patel Gautam Director | Conversion | +12,887,433 | 12,887,433 | ||
| 2019-11-11 | Patel Gautam Director | Other disposition | −12,887,433 | 17,497,336 | ||
| 2019-11-11 | Patel Gautam Director | Conversion · Common Units | −12,887,433 | 17,497,336 | ||
| 2019-08-28 | Nark Ted C Director | Purchase | +50,000 | $2.39 | $120K | 56,107 |
| 2019-08-16 | Bhadauria Pradeep SVP, Chief Scientific Officer | Purchase | +30,000 | $2.41 | $72K | 37,500 |
| 2019-08-07 | BOYER ANDREW S Exec VP, Comm Optns | Purchase | +66,666 | $2.89 | $193K | 95,968 |
| 2019-08-06 | Fosun International Ltd 10% owner | Purchase | +327,000 | $2.91 | $952K | 327,000 |
| 2019-08-05 | Fosun International Ltd 10% owner | Purchase | +1,642,300 | $3.04 | $5.0M | 1,642,300 |
Page 37 of 43 · 846 trades